Automated Breast Ultrasound Systems (ABUS) Market Rising Awareness About Breast Cancer to Propel Market Growth

An intelligence report on the global automated breast ultrasound systems (ABUS) market has been added to the portfolio of It is titled, “Automated Breast Ultrasound Systems (ABUS) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025.”


Albany, NY -- (SBWIRE) -- 02/07/2018 -- The ultrasound is an equipment which is used in the medical industry to carry out many procedures, such as detection of abnormalities, checking internal organs, diagnosing pregnancies, and so on.

Owing to the advancement in technology, the ultrasound devices are experiencing a huge demand in various applications in the healthcare industry in the past few years. The automated breast ultrasound systems are designed to detect even the tiny lumps inside the dense tissues of the breasts. This helps in more accurate diagnosis and efficient detection of tumor in the breasts. These automated breast ultrasound devices beat conventional handheld ultrasound devices in functionality on account of being more precise and effective.

The rise in awareness about the symptoms of breast cancer among the masses, alongside growth in radiology market is majorly fuelling the automated breast ultrasound systems (ABUS) market. Moreover, several organizations and healthcare centers are readily investing in research and development activities in order to better the imaging technique. This is also propelling the global market too. Another factor having a positive influence on the market is the initiatives being undertaken by governments of several countries to up breast cancer awareness.

For Sample Copy, click here:

However, there are certain factors that are anticipated to hamper the growth of global automated breast ultrasound systems (ABUS) market. Rise in expenses of radiation therapy, high magnetic resonance imaging cost, increased cost of maintenance, less expertise in the sector are some of them. Nevertheless, coronal view, clear 3D images, and better and efficient diagnosis, coupled with reduced turnaround time are some of the supporting factors that help the market overcome the challenges and expand steadily.

The automated breast ultrasound systems (ABUS) market is mainly segmented on the basis of region and end-user. Based on end-users, the market is divided into clinics, diagnostic centers and hospitals, and ambulatory surgical units. Among these, the hospital segment is estimated to grow at a significant pace within the forecast period from 2017 to 2025. This growth can be credited to the merger of hospital chains with the private firms in the market, along with increase in the number of patients coming for breast cancer screening to the hospitals.

View full report here @

Apart from this, as per geography, the ABUS market is segmented into Asia Pacific, North America, Europe, the Middle East and Africa, and Latin America. Out of these regions, North America holds the majority of the share in the global automated breast ultrasound systems market (ABUS), because of the existence of several prominent players in the region, along with increasing cases of breast cancers in the U.S. Rise in spending capacity is also one of the key reason for the growth of the market in the region.

North America is trailed by Asia Pacific in terms of market share, since it has enormous scope of growth owing to rise in awareness about breast cancer, efforts by non-profit organizations and governments to stamp out breast cancer by identifying its symptoms early on through collaborations with private companies and hospitals, and increase in healthcare expenses.

Koninklijke Philips N.V. (Netherlands), SonoCine Inc. (U.S.), General Electric Company (U.S), Hitachi, Ltd.(Japan), and Siemens AG (Germany) are some of the key players investing and flourishing in the global automated breast ultrasound systems market. One of the key strategies followed by the leading firms to grow their stronghold is mergers and acquisitions.

To order report Call Toll Free: 866-997-4948 or send an email on